International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
What Patients With Cancer Should Know About Radiation Side Effects
2
When the Fear of Cancer Creeps Back
3
Hernexeos Effective in HER2-Mutated NSCLC
4
BOLD Program Supports Patients With Cancer at Montefiore Einstein Comprehensive Cancer Center
5
